Korea

The Honest Farmer Targets Vietnam's Growing Healthy Snack Market with Black Barley Brown Rice Chips

SEOUL, South Korea, Dec. 4, 2025 /PRNewswire/ -- THE HONEST FARMER Co Ltd, a Korean producer of healthy snack foods, announced that it is accelerating its entry into the Vietnamese market with its signature product, the Black Barley Brown Rice Chip. Based in Yeongcheon, Gyeongsangbuk-do, the comp...

2025-12-05 11:00 2039

UMED Wins CES Innovation Awards® 2026, Redefining Bladder Care with World's First Automated Irrigation System

Transforming bladder care from hospital-centered procedures to accessible, data-driven digital urology SEOUL, South Korea, Dec. 4, 2025 /PRNewswire/ -- UMED Inc, an AI-driven urology-focused healthcare startup, announced that its automated bladder irrigation system, UroRinse™ Light, has been nam...

2025-12-04 15:08 1487

Korea's Startups Poised for a Landmark Season as COMEUP 2025 and CES 2026 Draw Near

SEOUL, South Korea, Dec. 3, 2025 /PRNewswire/ -- Korea is preparing for a defining season in global innovation, asSeoul readies for COMEUP 2025—hosted by the Ministry of SMEs and Startups—and Korean entrepreneurs mark final preparations for their annual journey toLas Vegas for CES 2026. The two s...

2025-12-04 02:00 2443

Celltrion announces U.S. FDA approval of 300mg strength of OMLYCLO® (omalizumab-igec), the first and only FDA-approved interchangeable biosimilar to XOLAIR®

* FDA approval of OMLYCLO® (omalizumab-igec) 300 mg/2 mL solution in a single-dose prefilled syringe for subcutaneous injection expands dosing flexibility and supports tailored treatment for individual patients with certain allergic diseases * OMLYCLO® (omalizumab-igec) is the first and only ...

2025-12-03 08:43 3734

"Sustainable Green Technology Enters the Home" -- ALLUONE's Smart Garden Pioneers Eco-Friendly Innovation

SEOUL, South Korea, Dec. 2, 2025 /PRNewswire/ -- ALLUONE Co., Ltd., an innovative company specializing in the development, manufacturing, and supply of IoT-based smart gardens, has introduced "Watering Garden," an eco-friendly solution that enables the creation of a sustainable green ecosystem ri...

2025-12-03 08:00 1638

Lunit to Highlight New AI Evidence in Cancer Screening and Breast Density-Driven Risk Modeling at RSNA 2025

Eight oral presentations and six posters demonstrate advances in mammography, DBT performance, and density-informed risk modeling SEOUL, South Korea, Dec. 2, 2025 /PRNewswire/ -- Lunit, a leading provider of AI for cancer diagnostics and precision oncology, today announced it will present 14 stu...

2025-12-02 22:10 4934

SPC Group's Paris Baguette expands its global store count to 700, adding a new location in Westfield London

* The new milestone came only 13 months after the opening of the 600th store * Paris Baguette is aggressively expanding its franchise footprint in Europe, building on its success in the US andChina * The multi-unit franchise operation demonstrates the brand's competitiveness and franchise p...

2025-12-02 22:00 1419

Neurophet Appoints Josh Cohen, Former Executive from a Global Medical AI firm, as Head of Americas Business -- To Accelerate U.S. Market

* Expert in sales and commercial strategy…Ex-Philips and previously served as Chief Commercial Officer (CCO) at Cortechs.ai * To strengthen revenue growth of AI-based brain imaging solutions in the North American market and expand product deployment across healthcare institutions SEOUL, South...

2025-12-02 22:00 4019

L&C Bio's 'Re2O' Emerges as a Leading K-Medical Tour Procedure Within One Year of Launch

– Surging global demand drives rapid adoption across domestic and international medical sectors – SEONGNAM, South Korea, Dec. 2, 2025 /PRNewswire/ -- L&C Bio (KOSDAQ: 290650, Co-CEOsHwan-Chul Lee and Jae-Ho Lee), a leading company in human tissue–based regenerative medicine, announced that its p...

2025-12-02 22:00 1231

Yuyu Pharma Announces Strategic Investment in Dalan Animal Health as Part of Accelerated Global Expansion in Animal Health

SEOUL, South Korea, Dec. 2, 2025 /PRNewswire/ -- Yuyu Pharma announced today that it has completed a strategic investment in Dalan Animal Health, a U.S.-based biotechnology company advancing an innate immunity–based platform for developing vaccines for honeybees and shrimp. The investment marks a...

2025-12-02 22:00 3431

HoneyNaps' AI Sleep-Diagnosis Software SOMNUM™ Selected as a 2025 Next Generation World Class Product at MOTIR Certification Ceremony

* Recognized at the official 2025 World Class Product of Korea Certification Ceremony held at Lotte Hotel World,Seoul * Certification affirms SOMNUM's potential to lead the global market within seven years * HoneyNaps accelerates global expansion: "We aim to become Korea's leading SleepT...

2025-12-02 19:00 1969

MegazoneCloud Wins AWS APJ "Consulting Partner of the Year" Award for the Second Consecutive Year

-    Simultaneously Receives APJ "Consulting Partner of the Year" and "Public Sector Consulting Partner of the Year" SEOUL, South Korea, Dec. 2, 2025 /PRNewswire/ -- MegazoneCloud, a leading cloud managed service provider, has received two "Partner of the Year" awards from Amazon Web Services (A...

2025-12-02 14:32 3799

GC Biopharma's Varicella Vaccine Strain 'MAV/06' Listed in WHO Position Paper

* Officially recognized by WHO as a standard varicella vaccine strain alongside Oka * Interchangeability endorsed, enhancing global supply security YONGIN, South Korea, Dec. 2, 2025 /PRNewswire/ -- GC Biopharma (006280.KS), a global biopharmaceutical company, today announced that its propriet...

2025-12-02 13:00 2469

Daesang to Participate in "FiE 2025" in Paris, Strengthening Global Ingredient Competitiveness

- To be held over three days from the 2nd to the 4th in Paris, France, with 1,550 companies and more than 24,000 visitors expected. - Specialty ingredients including amino acids and microalgae to be showcased, along with tasting sessions featuring dishes made with the natural seasoning ingredien...

2025-12-01 21:00 2269

ALLUONE Launches Customized Solution as the Plant-Care Market Continues to Grow

SEOUL, South Korea, Nov. 27, 2025 /PRNewswire/ -- As "pet plants" emerge as a new healing trend following the rise of pet ownership, ALLUONE is drawing market attention with the launch of Watering Garden, an automated solution designed to support the health and growth of companion plants. Wateri...

2025-11-28 08:00 1355

GC Genome Publishes Blood-Based Colorectal Cancer Screening Study in the American Journal of Gastroenterology

YONGIN, South Korea, Nov. 27, 2025 /PRNewswire/ -- GC Genome, a leading clinical genomics and liquid biopsy company, announced that its collaborative study with Professor Byeon, Jeong-Sik's team at Asan Medical Center has been published inThe American Journal of Gastroenterology(AJG). GC Genom...

2025-11-27 13:00 2805

SK Biopharmaceuticals Expands Radiopharmaceutical Therapy Portfolio with Second In-licensed Candidate from Wisconsin Alumni Research Foundation

New addition strengthens SK Biopharmaceuticals' radiopharmaceutical therapy portfolio and reinforces its R&D capabilities through global partnerships and value chain integration SEOUL, South Korea, Nov. 26, 2025 /PRNewswire/ -- SK Biopharmaceuticals, CO., Ltd., a biotech company specializing in ...

2025-11-27 10:39 1753

Beyless Achieves ASPICE CL2 Certification for In-Vehicle System Software Quality

SEOUL, South Korea, Nov. 26, 2025 /PRNewswire/ -- Beyless, a leading mobility software technology company, announced onNovember 14 that it has obtained ASPICE Level 2 (CL2) certification, an international automotive software quality assessment standard.

2025-11-27 09:00 1447

Nota AI Signs Technology Collaboration Agreement with Samsung Electronics for Exynos AI Optimization

"Driving the Popularization of On-Device Generative AI" -    Nota AI's optimization technology integrated into Samsung Electronics' Exynos AI Studio, enhancing efficiency in on-device AI model development SEOUL, South Korea, Nov. 26, 2025 /PRNewswire/ -- Nota AI, a company specializing in AI mo...

2025-11-26 21:00 2506

Celltrion announces publication of post-hoc analysis of LIBERTY-CD study of ZYMFENTRA®  (infliximab-dyyb), indicating consistent efficacy across disease location, including the terminal ileum in Clinical Gastroenterology and Hepatology journal

* Findings from the post-hoc analysis of LIBERTY-CD study indicates efficacy of ZYMFENTRA® (subcutaneous infliximab) regardless of disease location, consistent across ileum-dominant and colon-dominant Crohn's disease (CD) * Findings support the therapeutic potential of ZYMFENTRA in addressing ...

2025-11-26 14:48 3802
1 ... 15161718192021 ... 141